首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
【24h】

Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.

机译:果胶/壳聚糖/ Eudragit RS的游离混合膜的制备和表征,用于乙状结肠给药。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Polyelectrolyte complex (PEC) film between pectin as an anionic polyelectrolyte and chitosan as a cationic species was prepared by blending two polymer solutions at weight ratio of 2:1 and then solvent casting method. Besides pectin/chitosan PEC film, Eudragit RS, pectin/Eudragit RS and pectin/chitosan/Eudragit RS films were also prepared by aforementioned method. In mixed-film formulations, a fixed weight ratio of 1:5 of pectin or pectin/chitosan complex to Eudragit RS was used. Characterizations of pectin/chitosan interaction in solution were investigated by turbidity and viscosity measurement and in the solid state by Fourier transform infrared (FTIR) spectroscopy, wide angle X-ray diffraction (WAXRD) and thermogravimetric analysis (TGA). It was observed that the swelling profile of pectin/chitosan film was pH-dependent and its swelling ratio in phosphate buffer solution (PBS) pH 7.4 was about 2.5-fold higher than that of PBS pH 6.0. Formulation containing only pectin/chitosan could not protect freefilm from high swelling in the aqueous media, therefore, Eudragit RS as a water-insoluble polymer must be included in the mixed-film. The formation of PEC between pectin and chitosan resulted in a decrease in the crystallinity and thermal stability caused by the interactions between polyions. Drug permeation or diffusion studies were carried out using Plexiglas diffusion cell consisting of donor and acceptor compartments. Theophylline was selected as a model drug to measure permeability coefficient. Drug permeation through pectin/chitosan/Eudragit RS showed a sigmoidal pattern; whereas drug diffusion through pectin/Eudragit RS and Eudragit RS films followed a linear characteristic. The drug permeation through the ternary mixed-film showed a burst release upon exposure to PBS pH 6.0. This mixed-film formulation showed the potential for sigmoidal drug delivery with an initial, controllable slow release followed by a burst release immediately after the change in pH. The burst drug permeation might possibly be due to change in film's porosity.
机译:通过将两种聚合物溶液以2:1的重量比混合,然后采用溶剂流延法,制得果胶(作为阴离子型聚电解质)和壳聚糖(作为阳离子型)之间的聚电解质复合物(PEC)膜。除了果胶/壳聚糖PEC膜之外,还通过上述方法制备了Eudragit RS,果胶/ Eudragit RS和果胶/壳聚糖/ Eudragit RS膜。在混合膜配方中,使用了果胶或果胶/壳聚糖复合物与Eudragit RS的固定重量比为1:5。通过浊度和粘度测量以及在固态下通过傅立叶变换红外(FTIR)光谱,广角X射线衍射(WAXRD)和热重分析(TGA)研究了果胶/壳聚糖在溶液中的相互作用。观察到果胶/壳聚糖膜的溶胀曲线是pH依赖性的,并且其在pH 7.4的磷酸盐缓冲溶液(PBS)中的溶胀率比PBS pH 6.0的溶胀率高约2.5倍。仅包含果胶/壳聚糖的制剂不能保护自由膜免受水性介质中的高溶胀的影响,因此,在混合膜中必须包括作为水不溶性聚合物的Eudragit RS。果胶和壳聚糖之间的PEC的形成导致结晶度和热稳定性的下降,这是由聚离子之间的相互作用引起的。使用由供体和受体区室组成的有机玻璃扩散池进行药物渗透或扩散研究。选择茶碱作为模型药物以测量通透性系数。通过果胶/壳聚糖/ Eudragit RS的药物渗透呈S形。而通过果胶/ Eudragit RS和Eudragit RS膜的药物扩散具有线性特征。通过三元混合膜的药物渗透在暴露于PBS pH 6.0时显示出突发释放。这种混合膜制剂显示出乙状结肠药物输送的潜力,pH值变化后立即开始可控的缓慢释放,然后突然释放。破裂的药物渗透可能是由于薄膜孔隙率的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号